Introduction
============

Huntington\'s disease (HD) is a fatal neurodegenerative disease characterized by choreiform movements, personality changes, and dementia. HD is caused by a CAG trinucleotide expansion in exon 1 of the huntingtin gene (HTT) ([@b1-mmr-17-03-4317]). Degenerative changes and cell death occur in extensive brain regions and outside the central nervous system (CNS), particularly involving the striatum; HD currently lacks effective treatment ([@b2-mmr-17-03-4317]). As a consequence, HD results in cognitive and motor dysfunctions, involving speech, thought, psychiatric problems and involuntary muscle movements ([@b3-mmr-17-03-4317]).

Over the years, studies on various pathological mechanisms including endoplasmic reticulum stress, oxidative stress, axonal transport, autophagy, excitotoxicity, mitochondrial function, the ubiquitin proteasome system ([@b4-mmr-17-03-4317]), transcriptional deregulation and apoptosis have been implicated in HD ([@b5-mmr-17-03-4317]). Among these, various molecular and cellular dysfunctions were shown to originate from mutant HTT (mHTT); transcriptional dysregulation is considered to be one of the most important events ([@b6-mmr-17-03-4317]). Transcription factors (TFs) including CBP ([@b7-mmr-17-03-4317]), p53 ([@b8-mmr-17-03-4317]), Sp1 ([@b9-mmr-17-03-4317]), NFkB, and TBP are recruited to aggregates formed by mHTT ([@b10-mmr-17-03-4317]). Furthermore, HTT and mHTT are expressed in multiple tissues and can alter the transcription of miRNAs, such as miRNA-214, −150, −146a, and −137, which have been shown to target the HTT gene ([@b11-mmr-17-03-4317]).

Gene expression profile analysis is a fast, high-throughput method for detecting mRNA expression in tissues or cells. By comparing the different gene expression between HD models and healthy controls, a better understanding of the pathogenesis of HD can be acquired, facilitating the identification of potential target genes for therapy. Recent studies have suggested that bioinformatics mining and network analysis play an important role in studying and predicting the etiology in various neurodegenerative diseases, including HD ([@b12-mmr-17-03-4317]--[@b14-mmr-17-03-4317]).

The present study used the data from Sadri-Vakili *et al* ([@b15-mmr-17-03-4317]) and the DEGs between STHdh111/111 and STHdh7/7 were identified. Possible functions were predicted using enrichment analysis; protein-protein interaction (PPI) networks were visualized and module analysis was conducted to screen for key genes in STHdh111/111. In addition, we predicted a new regulatory pathway involving miRNAs, TFs, and their target genes. We aimed to explore the pathogenesis of HD using a computational bioinformatics analysis of gene expression.

Materials and methods
=====================

### Affymetrix microarray data

Derivation of genetic data gene expression profile (GSE11358) was downloaded from a national center for biotechnology information GEO (<http://www.ncbi.nlm.nih.gov/geo/>) database. Experiments were designed to compare the changes of mRNA expression between wild and mutant HD mouse models by histone acetyltransferase inhibitor intervention. Four STHdh cell lines were used, expressing full-length versions of mutant 111 glutamines (STHdh111/111), along with four wild-type cell lines containing seven glutamines (STHdh7/7). The base data was built on the platform of GPL1261 and analyzed based on the affymetrix mouse genome 430 2.0 array. In this study, GSE11358 was downloaded from a public database; therefore, patient consent ethics committee approval was not required.

### Data pre-processing and analysis of DEGs

Original data was first converted into identifiable expression forms; the limma package (linear models for microarray data) in R language was used to identify DEGs between STHdh111/111 and STHdh7/7 ([@b16-mmr-17-03-4317]). P-values of the DEGs were calculated separately and adjusted using the t-test method, and testing correction was performed using a Benjamini-Hochberg false discovery rate (HB FDR) ([@b17-mmr-17-03-4317]), DEGs with FDR\<0.05 and \|log fold change (FC)\|\>2 were used as thresholds.

### Functional and pathway enrichment analysis

DAVID (database for annotation visualization and integrated discovery) online analysis tools constitute a comprehensive biological information database. The system can mine biological functions of a large number of genes and protein ID, and play a key role in further gene biological information extraction. Its website is <http://david.abcc.ncifcrf.gov> ([@b18-mmr-17-03-4317]). Gene ontology database (GO; [www.geneontology.org](www.geneontology.org)) depicts basic characteristics of genes and gene products ([@b19-mmr-17-03-4317]). The Kyoto encyclopedia of genes and genomes (KEGG; [www.genome.jp/kegg/](www.genome.jp/kegg/)) ([@b20-mmr-17-03-4317]) pathway enrichment analysis was performed for identified DEGs using DAVID. Enriched terms with more than two genes and P values \<0.01 were considered to be statistically significant.

### Construction of a PPI network and analysis

The search tool for the retrieval of interacting genes (STRING <http:/string.embl.de/>) is an online database that has been designed as a comprehensive perspective to evaluate interaction information of proteins ([@b21-mmr-17-03-4317]). In the present study, STRING was used to obtain a protein-protein interaction (PPI) network of DEGs, and subsequently visualized using Cytoscape ([@b22-mmr-17-03-4317]). A confidence score of 0.4 was selected as the cut-off criterion. Molecular complex detection (MCODE) was then performed to screen modules of the PPI network with a degree cut-off=2, node score cut-off=0.2, k-core=2, and max, depth=100 ([@b23-mmr-17-03-4317]). The functional enrichment analysis of genes was performed by DAVID in each module.

### MicroRNAs prediction and transcription factor analysis

Biological targets of miRNAs were predicted by using TargetScan, which is one of the most commonly used bioinformatics target prediction tools ([@b24-mmr-17-03-4317]). In the present study, we chose the threshold of a region of 8mer seeds, which were completely matched for miRNA prediction. The TRANSFAC database is one of the most commonly used platform for the description and analysis of gene regulatory events and networks. It provides information about eukaryotic TFs, DNA-binding sites and DNA-binding profiles ([@b25-mmr-17-03-4317]). In this study, we selected the TRANSFAC database for the description and prediction of TFs.

Results
=======

### Identification of DEGs

A total of 471 DEGs including 319 upregulated and 152 downregulated DEGs were selected. This set of DEGs was used for hierarchical clustering analysis ([Fig. 1](#f1-mmr-17-03-4317){ref-type="fig"}).

### Functional and pathway enrichment analysis

Upregulated genes in the STHdh111/111 cells were significantly enriched in 208 GO terms and 25 KEGG pathways. The top ten functions enriched for upregulated genes are presented in [Table I](#tI-mmr-17-03-4317){ref-type="table"}, including extracellular region (P=1.49×10^−28^) and immune system process (P=2.53×10^−19^). Downregulated genes in the STHdh111/111 cells were significantly enriched in 159 GO terms and 16 KEGG pathways. The top ten functions enriched for downregulated genes are presented in [Table II](#tII-mmr-17-03-4317){ref-type="table"}, including cell adhesion (P=5.06×10^−7^), protein binding (P=3.08×10^−7^), and cytoplasm (P=3.28×10^−6^).

Pathways enriched for upregulated genes included cytokine-cytokine receptor interaction (P=9.18×10^−8^), the cytosolic DNA-sensing pathway (P=3.39×10^−7^) and the Jak-STAT signaling pathway (P=5.15×10^−5^), presented in [Table III](#tIII-mmr-17-03-4317){ref-type="table"}. In addition, downregulated genes were significantly enriched in the p53 signaling pathway (P=2.23×10^−3^), the regulation of actin cytoskeleton (P=0.032) and the hippo signaling pathway (P=0.036), presented in [Table IV](#tIV-mmr-17-03-4317){ref-type="table"}.

### PPI network construction and analysis

The PPI network of DEGs was constructed by Cytoscape software following a PPI search ([Fig. 2](#f2-mmr-17-03-4317){ref-type="fig"}). Using the MCODE in Cytoscape, degrees≥10 was set as the cutoff criterion and a total of 18 genes were selected as hub genes (DHX58, HERC6, RTP4, IFI44, STAT2, MX2, STAT1, IRF9, CXCL10, IFIT2, USP18, ISG15, OASL2, IFIT1, RSAD2, IRF7, DDX58, and IFIT3) were identified from the PPI network ([Fig. 3](#f3-mmr-17-03-4317){ref-type="fig"}). Notably, there were higher degrees in IFIT1 and OASL2 (degree=20) in the PPI network for upregulated genes, and in DDX58 and HERC6 (degree=20) in the PPI network for downregulated genes.

### miRNA prediction of DEGs

From the 471 DEGs investigated by this study, we chose a DEG with the largest log fold change (FC) value for miRNA prediction and analysis, which was RNASE4. We mapped the RNASE4 (log FC=9.11, P Value=1.32×10^−07^) in the TargetScan database for predicting the miRNAs of this gene. By choosing the strict cutoff of 8mer seeds, we found two miRNAs: miRNA-124a and miRNA-124a2.

### Transcription factor prediction of DEG

We searched the TFs of the RNASE4 gene by using the TRANSFAC database. Ten TFs were identified, including nuclear factor (NF)-κB1, c-Jun, c-Fos, hepatocyte nuclear factor (HNF)-4 α1, HNF-4 α2, activating protein-1 (AP-1), myocyte enhancer binding factor 2 (aMEF-2), signal transducer and activator of transcription 3 (STAT3), and cAMP-response element binding protein (δCREB; [Fig. 4](#f4-mmr-17-03-4317){ref-type="fig"}). The image displays the most relevant transcription factor binding sites in the promoter region of this gene as predicted by TRANSFAC database ([@b25-mmr-17-03-4317]). We predicted the miRNAs of these identified TFs and found that only STAT3 was associated with miRNA-124.

Discussion
==========

In this study, bioinformatics analysis of GSE11358 was carried out; we identified a total of 471 DEGs in STHdh111/111 cells compared with normal STHdh7/7 cells, including 319 upregulated and 152 downregulated genes. Upon analysis by MCODE in Cytoscape, 18 modules were identified from the PPI network, including DHX58, HERC6, RTP4, IFI44, STAT2, MX2, STAT 1, IRF9, CXCL10, IFIT2, USP18, ISG15, OASL2, IFIT1, RSAD2, IRF7, DDX58, and IFIT3. Of these, IFIT1 and OASL2 had the highest degree in upregulated genes, while DDX58 and HERC6 had the highest degree in downregulated genes.

IFIT1 was identified as a member of a macrophage 'core response module', which was commonly differentially expressed in response to multiple stimulatory signals in the immune system ([@b26-mmr-17-03-4317]). Interestingly, previous studies have demonstrated that both innate and adaptive immune systems were activated during progression of HD ([@b27-mmr-17-03-4317]). Dysregulation of IFIT1 can cause a measurable effect in the expression of downstream targets, acting either directly or indirectly, and IFIT1 was associated with a cluster of genes related to the innate immune response. Bayram-Weston *et al* found that IFIT1 was highly expressed in the striatum of the YAC128 and HdhQ150 mouse models of Huntington\'s disease ([@b28-mmr-17-03-4317]); Jordanovski *et al* also found that high expression of IFIT1 was correlated with Huntington\'s disease in the study of the TF ZNF395 ([@b29-mmr-17-03-4317]). All these results suggested that IFIT1 plays an important role in the immune response by regulating macrophage function, and its abnormal regulation could be involved in the pathophysiological changes of HD. However, the exact regulatory mechanism is unclear, and further experiments are needed to define the mechanism in HD. OASL2, as an interferon-stimulated gene is another gene related to the innate immune response ([@b30-mmr-17-03-4317]), and was shown to be an important response module in macrophage activation ([@b31-mmr-17-03-4317]). In the BACHD mouse model of HD, impaired migration of macrophages in response to an inflammatory stimulus was shown, which predicted one of the underlying mechanisms of HD ([@b32-mmr-17-03-4317]). McDermott *et al* reported that OASL2 participates in interactions that are important for macrophage activation and migration ([@b33-mmr-17-03-4317]). Dysregulation of OASL2 may interrupt migration of macrophages in the HD mice model or interact with mHTT fragments in their immunological functions.

DDX58, also known as retinoic acid inducible gene-I (RIG-I), has been validated by immunofluorescence labeling of motor neurons in an amyotrophic lateral sclerosis mouse(TDP-43A315T) spinal cord ([@b34-mmr-17-03-4317]). DDX58 is a direct target of TDP-43, and abnormalities of TDP-43 were shown to lead to deregulation of DDX58. Tauffenberger *et al* confirmed the results that inappropriate cytoplasmic accumulations of TDP-43 are observed in HD ([@b35-mmr-17-03-4317]). In our study, we found that DDX58 was clearly downregulated, which inferred that abnormal accumulations of TDP-43 in HD could be responsible for this result. Other studies also found that DDX58 was involved in immune regulation ([@b36-mmr-17-03-4317]).

HERC6 is a HerC protein family member; a previous study found that HERC6 was the main E3 ligase for global ISG15 conjugation in mouse cells ([@b37-mmr-17-03-4317]). ISG15, an interferon (IFN)-stimulated gene, was reported to participate in activation of IFN signaling in the CNS and was usually associated with inflammation ([@b38-mmr-17-03-4317]). Together, some studies indicated that ISG15 could activate autophagy by various means ([@b39-mmr-17-03-4317]). Although there were no exact studies reporting a correlation between HERC6 and HD, it has been established that aberrant inflammation and autophagy may both participate in the pathogenesis of HD; therefore, we believe that HERC6 may play a role in the etiology of HD by influencing the function of ISG15.

KEGG pathways, in our present study, including the Jak-STAT signaling pathway ([@b37-mmr-17-03-4317]), the toll-like receptor signaling pathway ([@b13-mmr-17-03-4317],[@b40-mmr-17-03-4317]), and the RIG-I-like receptor signaling pathway ([@b41-mmr-17-03-4317]) have been confirmed to be associated with HD and neurodegenerative diseases. Although we did not explore these pathways further in the present study, they are critical for understanding the pathogenesis of HD.

MicroRNA (miRNA) is a small non-coding RNA molecule containing about 22 nucleotides, and mediates the post-transcriptional regulation of gene expression ([@b42-mmr-17-03-4317]). It has been reported that miRNA is abundantly expressed in the CNS ([@b43-mmr-17-03-4317]) and may participate in diverse biological processes in neuronal cell differentiation and functions ([@b44-mmr-17-03-4317]). A number of different miRNAs have been found to be abnormally regulated in cellular and mice models of HD, including miRNA-137, −214 ([@b45-mmr-17-03-4317]), −146a ([@b46-mmr-17-03-4317]), and −27a ([@b47-mmr-17-03-4317]). Therefore, deregulated miRNAs could be attributed in etiology and therapeutic targets in the HD. Here, we tried to predict the miRNAs and TFs of DEGs in the HD mice model. We chose ribonuclease 4 (RNASE4), which is most significantly upregulated in HD (log FC=9.11). RNASE4, the fourth member of this superfamily, shares the same promoters as angiogenin (ANG), and is co-expressed with ANG ([@b48-mmr-17-03-4317]). It has been reported that RNASE4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress ([@b49-mmr-17-03-4317]). The neuroprotective activity of RNASE4 is similar to that of ANG, which can upregulate Bcl-2 ([@b50-mmr-17-03-4317]) and inhibit nuclear translocation of apoptosis-inducing factor ([@b51-mmr-17-03-4317]).

To strictly predict the miRNAs of the target gene RNASE4, we chose an exact match (8mer seed) to positions 2--8 of the mature miRNA. We found that miRNA-124 had the highest score, suggesting that miRNA-124 could play an important role in HD, which was in line with previous studies ([@b52-mmr-17-03-4317]). MicroRNA-124 has been implicated in HD by a mechanism that involves the regulation of CCNA2, and is involved in regulating the cell cycle ([@b53-mmr-17-03-4317]).

By searching TRANSFAC databases, we found STAT3 was also regulated by miRNA-124. Astrocyte reactivity is a hallmark of neurodegenerative diseases (ND); activation of the JAK/STAT3 pathway can promote astrocyte reactivity and decrease the number of huntington aggregates, a neuropathological hallmark of HD ([@b54-mmr-17-03-4317]). By analyzing new regulatory relationships between miRNA-124, STAT3 and RNASE4, we predicted a novel regulatory pathway that miRNA-124 regulates TF STAT3, and TF STAT3 regulates RNASE4, that is, miRNA-124→STAT3→RNASE4, which could be a possible target for HD treatment.

In the present study, we investigated the underlying mechanisms of HD via bioinformatics analysis. A total 471 DEGs were identified, and 18 hub genes including DHX58, HERC6, RTP4, IFI44, STAT2, MX2, STAT 1, IRF9, CXCL10, IFIT2, USP18, ISG15, OASL2, IFIT1, RSAD2, IRF7, DDX58, and IFIT3 may be involved in the progression of HD. Meanwhile, we found a new regulatory relationship between miRNA-124, STAT3 and RNASE4. All these findings can shed light on the complex pathogenesis of HD and provide a potential novel therapeutic strategy for patients with HD, but the bioinformatics findings obtained in this study require further conformation via experimental studies.

The present study was supported by the National Natural Science Foundation of China (no. 81371271), and was also sponsored by 'Liaoning BaiQianWan Talents Program'.
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![A significant module selected from the protein-protein interaction network by utilizing MCODE in Cytoscape. Lines represent an interacting relationship between nodes.](MMR-17-03-4317-g02){#f3-mmr-17-03-4317}

![Transcription factors of RNASE4 gene in the TRANSFAC database. The red arrow indicates the transcription starting site and direction of the RNASE4 gene. The green vertical lines indicate the transcription factor binding sites. NF, nuclear factor; CREB, cAMP-response element binding protein; HNF, hepatocyte nuclear factor; AP, activating protein; aMEF, myocyte enhancer binding factor; STAT3, signal transducer and activator of transcription 3; delta CREB, cAMP-response element binding protein.](MMR-17-03-4317-g03){#f4-mmr-17-03-4317}

###### 

Top 10 functions enriched for the upregulated genes in the STHdh111/111 cells.

  ID           Description                            P-value        Total no. of genes   Genes
  ------------ -------------------------------------- -------------- -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GO:0005576   Extracellular region                   1.49×10^−28^   93                   ASPN, AEBP1, FGF7, FAM3C, ARSJ, POSTN, LRRC17, MMP3, CXCL10, LOC100861978, NOV, OGN, C1RA, WISP2, C1RB, TNFRSF11B, CASP4, ISG15, SERPINE2, APOD, APOF, TGFBI, SEMA3E, RSPO2, CFH, BC028528, ANGPT1, SEMA3B, ITIH2, SEPP1, LBP, LOX, COL10A1, C4A, SPARCL1, ANG3, LIFR, MGP, NDNF, VEGFC, SERPINA3N, BGN, C4BP, SERPINA3M, ADM, EREG, COL1A2, ADAMTS1, ADAMTS5, HSD17B11, CXCL1, RBP4, IL1R1, WNT16, C3, ENPP2, LUM, CPQ, CLU, CXCL9, IL33, DCN, GBP2B, CCL5, ISLR, SMOC2, LGALS3BP, GLIPR1, FBN2, PTX3, COL8A2, THBS2, SVEP1, RNASE4, EFEMP1, IL1RN, IGF2, CLEC11A, LGALS9, GAS6, THSD7A, TSLP, OMD, LAMA4, SNED1, PENK, CLEC3B, CXCL15, TGFBR3, APOL9A, C1S1, IGFBP4, IGFBP5
  GO:0009615   Response to virus                      7.68×10^−23^   24                   IFIH1, BST2, CLU, OAS3, RSAD2, OAS2, CCL5, CXCL10, ISG20, DDX58, IFIT3, IFIT2, IFIT1, OASL2, DDX60, IFI27L2A, TGTP2, OAS1A, EIF2AK2, MX1, MX2, DHX58, DCLK1, ADAR
  GO:0051607   Defense response to virus              2.82×10^−21^   29                   IFIH1, SLFN9, CXCL9, OAS3, SLFN8, RSAD2, OAS2, IL33, GBP2B, CXCL10, ISG20, ISG15, OASL2, DDX60, MX1, MX2, DHX58, ZBP1, BST2, TRIM25, STAT2, H2×Q9, IFIT3, DDX58, IFIT2, IFIT1, OAS1A, EIF2AK2, ADAR
  GO:0002376   Immune system process                  2.53×10^−19^   38                   IFIH1, C3, OAS3, H2×D1, RSAD2, OAS2, GBP2B, ISG20, C1RA, C1RB, CASP4, OASL2, TAP1, CFH, IIGP1, LBP, MX1, MX2, DHX58, ZBP1, H2×K1, IRGM1, H2×L, BST2, HERC6, TRIM25, PSMB8, LGALS9, PSMB9, IFIT3, DDX58, IFIT2, IFIT1, C4BP, IRF7, C1S1, EIF2AK2, ADAR
  GO:0035458   Cellular response to interferonxbeta   4.27×10^−19^   17                   GBP6, IRGM1, IRGM2, LOC100044068, IFI47, STAT1, GBP2B, IFIT3, IFI202B, IFIT1, IGTP, IIGP1, TGTP2, GBP3, GM4951, GBP2, IFI204
  GO:0045087   Innate immune response                 5.67×10^−17^   36                   IFIH1, C3, TRIM14, OAS3, RSAD2, OAS2, ISG20, C1RA, C1RB, CASP4, OASL2, CFH, IIGP1, VNN1, LBP, PTX3, MX1, MX2, DHX58, ZBP1, IRGM1, LOC100044068, BST2, HERC6, TRIM25, IFI202B, DDX58, IFIT3, IFIT2, IFIT1, C4BP, IRF7, OAS1A, C1S1, EIF2AK2, ADAR
  GO:0005615   Extracellular space                    1.01×10^−16^   68                   AEBP1, FGF7, POSTN, LRRC17, DLK1, CXCL11, MMP3, CXCL10, LOC100861978, OGN, TNFRSF11B, WISP2, SERPINE2, APOD, SEMA3E, TGFBI, CFH, VNN1, ANGPT1, SEMA3B, CES1D, SEPP1, LOX, LBP, CTSZ, C4A, SPARCL1, MGP, VEGFC, SERPINA3N, THBD, SERPINA3M, ADM, EREG, PPBP, COL1A2, CTSH, ADAMTS5, CXCL1, RBP4, WNT16, IL1R1, ENPP2, C3, LUM, CPQ, CLU, CXCL9, OAS3, IL33, DCN, CCL5, ABI3BP, LGALS3BP, COL6A3, PTX3, EFEMP1, IL1RN, LMCD1, IGF2, GAS6, CLEC11A, TSLP, OMD, CLEC3B, CXCL15, TGFBR3, IGFBP4
  GO:0005578   Proteinaceous extracellular matrix     5.89×10^−16^   31                   ASPN, WNT16, LUM, POSTN, DCN, MMP3, ABI3BP, NOV, SMOC2, OGN, TNFRSF11B, LGALS3BP, WISP2, TGFBI, COL6A3, FBN2, LOX, THBS2, COL8A2, COL10A1, SPARCL1, EFEMP1, NDNF, LAMA4, OMD, BGN, CLEC3B, COL1A2, TGFBR3, ADAMTS1, ADAMTS5
  GO:0008201   Heparin binding                        1.79×10^−12^   20                   FGF7, POSTN, CCL5, CXCL11, ABI3BP, NDNF, CXCL10, NOV, SMOC2, OGN, WISP2, SERPINE2, CLEC3B, RSPO2, CFH, TGFBR3, ADAMTS1, GPNMB, THBS2, ADAMTS5
  GO:0031012   Extracellular matrix                   1.32×10^−11^   25                   ASPN, AEBP1, LUM, CLU, POSTN, DCN, MMP3, NOV, OGN, LGALS3BP, CD93, SERPINE2, COL6A3, TGFBI, FBN2, COL8A2, THBS2, EFEMP1, LMCD1, MGP, OMD, BGN, COL1A2, ADAMTS1, ADAMTS5

###### 

Top 10 functions enriched for the down regulated genes in the STHdh111/111 cells.

  ID           Description                          P-value       Total no. of genes   Genes
  ------------ ------------------------------------ ------------- -------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GO:0007155   Cell adhesion                        5.06×10^−7^   17                   FLRT2, CADM1, NUAK1, PDPN, ITGB5, ITGA3, NECTIN4, CDH2, MEGF10, NCAM1, HES1, WISP1, PKP1, CD34, TENM3, ITGA7, HAS2
  GO:0005515   Protein binding                      3.08×10^−7^   56                   ALDH1L1, CADM1, ATL2, AQP5, PAX6, PMAIP1, PRKG2, ANKRD1, CKB, WNT4, UNC5B, TIAM1, BOK, EMID1, PID1, KIF5C, BASP1, ECT2, HES1, NCAM1, KRT19, UHRF1, SIX1, BUB1B, WNT9A, KIF26B, MAP3K11, SOX2, BEX1, CDH2, SOX6, CEP55, IVNS1ABP, PEX5L, VDR, LHX2, POU3F3, SCN5A, OLFM1, DTNA, FLRT2, NES, TRPC6, IGF1, BIRC5, DPYSL3, ITGA3, SOD3, NREP, BMPER, PKP1, SFRP2, SALL1, ITGA7, ID4, FCGBP
  GO:0005737   Cytoplasm                            3.28×10^−6^   75                   ALDH1L1, CRABP1, PTGS2, TUBB2B, NUAK1, CRABP2, PTGS1, PAX6, RPRM, ANKRD1, CKB, WNT4, WISP1, BOK, TIAM1, PID1, CDC6, SGOL1, KIF5C, BASP1, UBE2C, ECT2, HES1, TNNT2, NCAM1, PPM1E, TAGLN, SPAG5, CD34, SIX1, BUB1B, HAS2, FILIP1L, GRB14, CASQ2, KIF26B, MAP3K11, FHL1, SOX2, DIAPH3, BEX1, ANLN, CDH2, DENND2A, CEP55, SERPINB1B, IVNS1ABP, PEX5L, TK1, ACSBG1, NCAPG, FNDC1, ENO3, DTNA, FLRT2, PTGR1, NES, GSTA4, TRPC6, IGF1, BIRC5, DPYSL3, C330027C09RIK, RGS16, SOD3, CENPI, FAM64A, NREP, SALL1, PRKAR1B, ITGA7, ID4, FAM84B, BTBD11, PLEKHA1
  GO:0000902   Cell morphogenesis                   2.80×10^−5^   7                    VDR, CAP2, PDPN, TENM3, SOX6, GREM1, ECT2
  GO:0051301   Cell division                        9.48×10^−5^   12                   CCNE2, CDC6, FAM64A, SPAG5, SGOL1, NUF2, BUB1B, BIRC5, ANLN, CEP55, UBE2C, ECT2
  GO:0007275   Multicellular organism development   1.72×10^−4^   20                   FLRT2, NES, CADM1, PDPN, FHL1, SOX2, PAX6, BEX1, SOX6, SHOX2, VDR, WNT4, UNC5B, SFRP2, SEMA7A, SIX1, POU3F3, WNT9A, OLFM1, KIF26B
  GO:0045165   Cell fate commitment                 1.82×10^−4^   6                    HES1, WNT4, SOX2, PAX6, SOX6, WNT9A
  GO:0007067   Mitotic nuclear division             2.00×10^−4^   10                   CDC6, FAM64A, SPAG5, SGOL1, NUF2, BUB1B, BIRC5, ANLN, CEP55, UBE2C
  GO:0008283   Cell proliferation                   2.14×10^−4^   9                    UHRF1, PDPN, BOK, CD34, PRKAR1B, SIX1, IGF1, ID4, MAP3K11
  GO:0005911   Cell-cell junction                   6.26×10^−4^   8                    NCAM1, FLRT2, CADM1, TIAM1, FNDC1, CDH2, NECTIN4, ECT2

###### 

Top 10 enriched pathways for the upregulated genes.

  ID         Description                              P-value        Total no. of genes   Genes
  ---------- ---------------------------------------- -------------- -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  mmu05168   Herpes simplex infection                 1.70×10^−11^   21                   H2-K1, IFIH1, SP100, SOCS3, C3, OAS3, H2-D1, OAS2, STAT1, CCL5, H2-Q6, STAT2, IRF9, DDX58, IKBKE, IFIT1, IRF7, TAP1, LOC101056305, OAS1A, EIF2AK2
  mmu05164   Influenza A                              4.28×10^−11^   19                   IFIH1, SOCS3, OAS3, RSAD2, TRIM25, IL33, OAS2, STAT1, CCL5, STAT2, CXCL10, IRF9, DDX58, IKBKE, IRF7, OAS1A, EIF2AK2, MX2, ADAR
  mmu04060   Cytokine-cytokine receptor interaction   9.18×10^−8^    18                   IL1R1, LTBR, OSMR, IL6ST, LIFR, CXCL9, ACKR3, CCL5, CXCL11, CXCL10, LOC100861969, LOC100861978, VEGFC, TSLP, TNFRSF11B, PPBP, CXCL15, IL13RA1
  mmu04623   Cytosolic DNA-sensing pathway            3.39×10^−7^    10                   IFI202B, DDX58, IKBKE, LOC100044068, IRF7, IL33, CCL5, ZBP1, ADAR, CXCL10
  mmu05160   Hepatitis C                              6.55×10^−7^    13                   SOCS3, OAS3, OAS2, STAT1, STAT2, IRF9, DDX58, IKBKE, IFIT1, IRF7, CLDN1, OAS1A, EIF2AK2
  mmu05162   Measles                                  6.55×10^−7^    13                   IFIH1, OAS3, OAS2, STAT1, STAT2, IRF9, DDX58, IKBKE, IRF7, OAS1A, EIF2AK2, MX2, ADAR
  mmu04630   Jak-STAT signaling pathway               5.15×10^−5^    11                   STAT6, IRF9, TSLP, OSMR, IL6ST, SOCS3, LIFR, STAT1, IL13RA1, STAT2, LOC100861969
  mmu04622   RIG-I-like receptor signaling pathway    5.87×10^−5^      8                  DDX58, IKBKE, IFIH1, ISG15, IRF7, TRIM25, DHX58, CXCL10
  mmu04620   Toll-like receptor signaling pathway     6.98×10^−4^      8                  IKBKE, IRF7, CXCL9, LBP, STAT1, CCL5, CXCL11, CXCL10
  mmu05203   Viral carcinogenesis                     2.17×10^−3^    11                   H2-K1, IRF9, LTBR, SP100, IL6ST, C3, IRF7, H2-D1, LOC101056305, EIF2AK2, H2-Q6

###### 

Top 10 enriched pathways for the downregulated genes.

  ID         Description                                                P-value       Total no. of genes   Genes
  ---------- ---------------------------------------------------------- ------------- -------------------- ------------------------------------------------------------
  mmu05414   Dilated cardiomyopathy                                     5.90×10^−4^   6                    TNNT2, ADCY7, ITGA7, IGF1, ITGB5, ITGA3
  mmu04550   Signaling pathways regulating pluripotency of stem cells   9.37×10^−4^   7                    INHBB, WNT4, SOX2, PAX6, IGF1, ID4, WNT9A
  mmu04923   Regulation of lipolysis in adipocytes                      1.22×10^−3^   5                    ADCY7, PTGS2, PTGS1, PDE3B, PRKG2
  mmu04115   p53 signaling pathway                                      2.23×10^−3^   5                    CCNE2, RPRM, IGF1, PMAIP1, IGFBP3
  mmu05412   Arrhythmogenic right ventricular cardiomyopathy (ARVC)     2.75×10^−3^   5                    TCF7, ITGA7, ITGB5, ITGA3, CDH2
  mmu05410   Hypertrophic cardiomyopathy (HCM)                          4.05×10^−3^   5                    TNNT2, ITGA7, IGF1, ITGB5, ITGA3
  mmu05200   Pathways in cancer                                         0.016         9                    CCNE2, TCF7, WNT4, ADCY7, PTGS2, IGF1, BIRC5, ITGA3, WNT9A
  mmu05205   Proteoglycans in cancer                                    0.026         6                    WNT4, TIAM1, IGF1, ITGB5, WNT9A, GPC1
  mmu04810   Regulation of actin cytoskeleton                           0.032         6                    TIAM1, ITGA7, DIAPH3, ITGB5, ITGA3, MYL9
  mmu04390   Hippo signaling pathway                                    0.036         5                    TCF7, WNT4, SOX2, BIRC5, WNT9A
